These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 1743591)

  • 1. A regimen for antithrombin III substitution in patients with acute lymphoblastic leukemia under treatment with L-asparaginase.
    Mattioli Belmonte M; Gugliotta L; Delvos U; Catani L; Vianelli N; Cascione ML; Belardinelli AR; Mottola L; Tura S
    Haematologica; 1991; 76(3):209-14. PubMed ID: 1743591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in antithrombin and fibrinogen levels during induction chemotherapy with L-asparaginase in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma. Use of supportive coagulation therapy and clinical outcome: the CAPELAL study.
    Hunault-Berger M; Chevallier P; Delain M; Bulabois CE; Bologna S; Bernard M; Lafon I; Cornillon J; Maakaroun A; Tizon A; Padrazzi B; Ifrah N; Gruel Y;
    Haematologica; 2008 Oct; 93(10):1488-94. PubMed ID: 18728028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. L-asparaginase in acute lymphoblastic leukemia treatment: the role of human antithrombin III concentrates in regulating the prothrombotic state induced by therapy.
    Pogliani EM; Parma M; Baragetti I; Mostarda G; Rivolta F; Maffé P; Corneo G
    Acta Haematol; 1995; 93(1):5-8. PubMed ID: 7725851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypercoagulability during L-asparaginase treatment: the effect of antithrombin III supplementation in vivo.
    Gugliotta L; D'Angelo A; Mattioli Belmonte M; Viganò-D'Angelo S; Colombo G; Catani L; Gianni L; Lauria F; Tura S
    Br J Haematol; 1990 Apr; 74(4):465-70. PubMed ID: 2189489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antithrombin supplementation III in childhood acute lymphoblastic leukemia treated with L-asparaginase.
    Matsuzaki A; Suminoe A; Hara T
    Pediatr Hematol Oncol; 2002 Dec; 19(8):601-3. PubMed ID: 12487838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erwinia- and E. coli-derived L-asparaginase have similar effects on hemostasis. Pilot study in 10 patients with acute lymphoblastic leukemia.
    Castaman G; Rodeghiero F
    Haematologica; 1993; 78(6 Suppl 2):57-60. PubMed ID: 8039761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of dose-reduced Medac L-asparaginase on coagulation in trial ALL-BFM 2000.
    Attarbaschi A; Mann G; Kronberger M; Witt V; Gadner H; Dworzak M
    Klin Padiatr; 2003; 215(6):321-6. PubMed ID: 14677096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombosis associated with L-asparaginase therapy and low fibrinogen levels in adult acute lymphoblastic leukemia.
    Beinart G; Damon L
    Am J Hematol; 2004 Dec; 77(4):331-5. PubMed ID: 15551293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correction of hemostatic imbalances induced by L-asparaginase therapy in children with acute lymphoblastic leukemia.
    Zaunschirm A; Muntean W
    Pediatr Hematol Oncol; 1986; 3(1):19-25. PubMed ID: 3153215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of glucocorticoids, E. coli- and Erwinia L-asparaginase on hemostatic proteins in children with acute lymphoblastic leukemia.
    Mall V; Thomas KB; Sauter S; Niemeyer CM; Sutor AH
    Klin Padiatr; 1999; 211(4):205-10. PubMed ID: 10472551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cerebral thrombosis in a child with acute lymphocytic leukemia during L-asparaginase therapy].
    Horigome Y; Hanada T; Inudoh M; Takita H
    Rinsho Ketsueki; 1989 Aug; 30(8):1284-8. PubMed ID: 2601047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithrombin III infusion suppresses the hypercoagulable state in adult acute lymphoblastic leukaemia patients treated with a low dose of Escherichia coli L-asparaginase. A GIMEMA study.
    Mazzucconi MG; Gugliotta L; Leone G; Dragoni F; Belmonte MM; De Stefano V; Chistolini A; Tura S; Mandelli F
    Blood Coagul Fibrinolysis; 1994 Feb; 5(1):23-8. PubMed ID: 7514043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemostatic changes in children with acute lymphoblastic leukemia treated according to two different L-asparaginase schedules.
    Miniero R; Pastore G; Saracco P; Messina M; Lange MM; Fiandino G; Iannacci L; Madon E
    Am J Pediatr Hematol Oncol; 1986; 8(2):116-20. PubMed ID: 3461716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Current national and international status of supportive therapy for the coagulopathy associated with L-asparaginase containing regimen for acute lymphoblastic leukemia].
    Ogawa C; Manabe A; Ohara A; Ishiguro A
    Rinsho Ketsueki; 2013 Mar; 54(3):316-8. PubMed ID: 23676650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Superior sagittal sinus thrombosis following L-asparaginase therapy of acute lymphoblastic leukemia].
    Watanabe I; Sakai I; Matsumoto I
    Rinsho Ketsueki; 1992 Mar; 33(3):343-8. PubMed ID: 1578639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased thrombin generation during fibrinogen and platelet recovery as an explanation for hypercoagulability in children with L-asparaginase therapy for ALL or NHL: a preliminary report.
    Korte W; Feldges A; Baumgartner C; Ullmann S; Niederer V; Schmid L
    Klin Padiatr; 1994; 206(4):331-3. PubMed ID: 7967434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombotic complications during L-asparaginase treatment for acute lymphocytic leukemia.
    Castaman G; Rodeghiero F; Dini E
    Haematologica; 1990; 75(6):567-9. PubMed ID: 2098299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fractionated cyclophosphamide added to the IVAP regimen (idarubicin-vincristine-L-asparaginase-prednisone) could lower the risk of primary refractory disease in T-lineage but not B-lineage acute lymphoblastic leukemia: first results from a phase II clinical study.
    Bassan R; Pogliani E; Lerede T; Fabris P; Rossi G; Morandi S; Casula P; Lambertenghi-Deliliers G; Vespignani M; Izzi T; Coser P; Corneo G; Barbui T
    Haematologica; 1999 Dec; 84(12):1088-93. PubMed ID: 10586210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombosis in children receiving L-asparaginase. Determining patients at risk.
    Shapiro AD; Clarke SL; Christian JM; Odom LF; Hathaway WE
    Am J Pediatr Hematol Oncol; 1993 Nov; 15(4):400-5. PubMed ID: 8214362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Coagulation disorders during treatment with l-asparaginase preparations].
    Dobaczewski G
    Wiad Lek; 1998; 51 Suppl 4():227-32. PubMed ID: 10731973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.